Seòmar agus comataidhean

From 2025-26 we will align the support we provide for pay uplifts in the hospice sector to the outcomes of the NHS Agenda for Change negotiations. This will ensure that hospices will get the additional funding needed to see their healthcare staff match pay increases with NHS staff.

The Scottish budget for 2025-26 includes £5 million of investment to support independent hospices to provide pay parity with NHS levels. Officials are working with the Chair of the Scottish Hospice Leadership Group to explore mechanisms for providing this funding to hospices, while respecting existing commissioning arrangements with Integration Joint Boards (IJBs).

Officials have recently received further information from hospice colleagues to support this work, and we look forward to engaging further with Scottish hospices once this exploratory work has concluded.

The Scottish Government published a draft palliative care strategy ‘Palliative care matters for all’ on 02 October 2024 for consultation. The consultation closed on 10 January 2025. The responses have now been analysed, and the final version of the strategy and analysis report are due to be published in the summer. The strategy will be published alongside a delivery plan, which will set out our approach to ensuring that everyone who needs it can access timely palliative care and care around dying.

No changes are currently planned to the questions asked in the Scottish National Blood Transfusion Service (SNBTS) donor health check questionnaire as a result of the Supreme Court judgment. However, SNBTS will continue to review its polices in the light of any further guidance issued.

The Scottish Government is grateful to everyone who takes the time to volunteer to give blood. The questionnaire aims to treat all potential donors equitably, but it is essential that all questions are answered fully in order to ensure that blood can be donated safely. Nonetheless, the Scottish Government regrets any upset caused to people who are not able to donate blood as a result of not answering any of the questions in the questionnaire.

SNBTS adjusted the questionnaire in 2022 so that all donors are asked the same questions. In response to some concerns raised, SNBTS further amended the questionnaire in 2023 to make clear that if the question about whether a donor might be pregnant is not applicable then donors should tick ‘No’. Although some questions will not be relevant for many donors – male and female – the questionnaire is the most practical way of asking sensitive questions in a busy donor environment. Staff cannot know or make assumptions in all cases about a person’s biological sex, so the current approach avoids any risk that someone who could be pregnant does not answer the pregnancy question.

The Heat in Buildings Programme was subject of an Audit Scotland review in 2023, with the findings of this review published in February 2024. This publication can be found at https://audit.scot/publications/decarbonising-heat-in-homes.

Additionally, all Scottish Government expenditure is subject to audit through the sampling of annual accounts.

The Scottish Government will be allocating an additional £6,252,000 to territorial boards in 2025-26 specifically to fund insulin pumps and continuous glucose monitors (CGM). Additional funding of around £800,000 will be used to fund the National Onboarding Service and make improvements to digital infrastructure, including SCI-Diabetes and MyDiabetes MyWay.

A breakdown of funding being provided to each territorial Board can be found in the following table. Some additional funding has been provided to support development of digital infrastructure.

Tovorafenib does not currently have a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). It is the responsibility of individual pharmaceutical companies to apply to the MHRA for a marketing authorisation. If a marketing authorisation is granted, the Scottish Medicines Consortium (SMC) would welcome a submission for tovorafenib, however the decision on whether to submit a medicine for appraisal to the SMC, and the timing of that submission, is entirely for the pharmaceutical company that holds the marketing authorisation for the medicine to make.

The four Health Boards providing regional services to those with Duchenne muscular dystrophy (DMD) have now started to contact all families with children eligible under the national early access programme to set out the timelines involved. In addition, the Chief Pharmaceutical Officer has been assured that the consultants have reviewed all those who are eligible to ensure fair and equitable access across Scotland.

The Scottish Government recognises the heightened risk of social isolation in rural areas. To support the delivery of our Social Isolation and Loneliness Delivery Plan, we are providing £3.8m over three years to 53 community projects across Scotland through the Social Isolation and Loneliness Fund that is providing opportunities for people to connect. At end of year one projects reached 11,293 individuals with a focus on priority groups most at risk of social isolation and loneliness. We continue to support the National Rural Mental Health Forum to build the confidence of rural organisations to deliver mental health support to their members and networks. We also provide funding to Befriending Networks, who support befriending services across Scotland, and currently have 118 Scottish members; of which approximately 1 in 4 members are independent community organisations operating in rural areas.

As outlined in the response to S6W-32069 on 6 January 2025, the Scottish Government expects all NHS Boards to provide maternity services that are delivered as close to home as practicable, balanced with ensuring the safety of mother and baby. Within the policies we set, it is for NHS Boards to determine the model of service delivery best suited to meet the needs of their local areas and population.

All decisions about care throughout pregnancy, including around place of birth, should be made by women in discussion with their clinical team. These decisions will take account of their individual needs and circumstances. To support this, in February 2025 we published the new Pathway for Maternity Care. This sets out the core care that women and their babies should receive under a whole-person, individualised care approach which takes account of their specific circumstances. We also published the new Birthplace Decision leaflet to provide women with the up-to-date information they need to make informed decisions about where they would like to give birth.

Women will be given advice when they contact maternity triage services in labour to help them make decisions about when to travel to hospital, and on pain relief options available to them.

All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers